124 related articles for article (PubMed ID: 38847627)
1. Assessment of Isoniazid Preventive Therapy and Incidence of Tuberculosis among People Living with Human Immunodeficiency Virus Seeking Care in an Anti-retroviral Therapy Center, Puducherry.
Kannusamy S; Sahu SK; Udayashankar C; Sarveswaran G; Roy G
Indian J Public Health; 2024 Jan; 68(1):15-20. PubMed ID: 38847627
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
[TBL] [Abstract][Full Text] [Related]
3. Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.
Dhungana GP; Thekkur P; Chinnakali P; Bhatta U; Pandey B; Zhang WH
BMJ Open; 2019 May; 9(5):e029058. PubMed ID: 31147370
[TBL] [Abstract][Full Text] [Related]
4. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
8. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
[TBL] [Abstract][Full Text] [Related]
9. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
10. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
Kazibwe A; Oryokot B; Mugenyi L; Kagimu D; Oluka AI; Kato D; Ouma S; Tayebwakushaba E; Odoi C; Kakumba K; Opito R; Mafabi CG; Ochwo M; Nkabala R; Tusiimire W; Kateeba Tusiime A; Alinga SB; Miya Y; Etukoit MB; Biraro IA; Kirenga B
PLoS One; 2022; 17(5):e0266285. PubMed ID: 35576223
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts.
Assefa DG; Zeleke ED; Bekele D; Ejigu DA; Molla W; Woldesenbet TT; Aynalem A; Abebe M; Mebratu A; Manyazewal T
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612942
[TBL] [Abstract][Full Text] [Related]
12. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
14. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
Maokola W; Ngowi B; Lawson L; Robert M; Mahande M; Todd J; Msuya S
Int J Infect Dis; 2021 Feb; 103():562-567. PubMed ID: 33276111
[TBL] [Abstract][Full Text] [Related]
15. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India.
Gupte AN; Kadam D; Sangle S; Rewari BB; Salvi S; Chavan A; Nimkar S; Golub J; Gupte N; Gupta A; Marbaniang I; Mave V
BMC Infect Dis; 2019 Oct; 19(1):914. PubMed ID: 31664933
[TBL] [Abstract][Full Text] [Related]
16. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
17. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study.
Denegetu AW; Dolamo BL
BMC Public Health; 2014 Jan; 14():52. PubMed ID: 24438508
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting.
Padmapriyadarsini C; Sekar L; Reddy D; Chitra A; Poornagangadevi N; Selvaraj M; Bhavani PK; Mothi SN; Nandagopal K; Vennila S; Tamizhselvan M; Maheshmanisha J; Agarwal U; Rewari BB; Swaminathan S
Indian J Med Res; 2020 Dec; 152(6):648-655. PubMed ID: 34145105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
